About Conference
This symposium will assemble top experts in the field to address the unmet clinical needs, and discuss how immunotherapy can reach patient populations that currently do not benefit.
Highlights
he program will explore how to overcome barriers to immune cell entry into tumors, as well as insufficient activation of anti-tumor immune responses. In addition, diverse immune cell therapies will be covered, from T-cell based mainstays like TILs, gene-modified T cells, and CAR-T cells, to emerging modalities deploying innate immune cells like dendritic and NK cells.
Find on Map
Recommended News For You
Recommended Articles For You
Featured News
Featured Articles
Featured Events
Featured KOL Videos
1.
Reduced Suicide Rates in Cancer Patients; Enhanced Circadian Rhythm; HIV Vaccine for Cancer Patients?
2.
DNA's hidden shape reveals target to reverse ovarian cancer chemoresistance
3.
For patients with prostate cancer, long-term follow-up helps identify treatment side effects.
4.
Can patients receiving immunotherapy for cancer benefit from taking vitamin D supplements?
5.
Chemotherapy can be a challenging treatment?here's how to deal with some of the side-effects
1.
Blastic Plasmacytoid Dendritic Cell Neoplasm and the Dawn of AI-powered Diagnostics
2.
Unlocking the Secrets of Squamous Cell Carcinoma: New Hope for Patients
3.
Precision Cancer Risk Mitigation Strategies
4.
Unlocking the Mysteries of Lymphoblastic Lymphoma: A Journey Into the Unknown
5.
Exploring the Use of Bevacizumab in Treating Different Types of Cancers
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VI
2.
Efficient Management of First line ALK-rearranged NSCLC - Part II
3.
First Line Combination Therapy- The Overall Survival Data in NSCLC Patients
4.
Guideline Recommendations of Lorlatinib as First-Line Treatment for ALK+ NSCLC
5.
Innovations in Hematology
Recommended News For You
1.
Classifying childhood brain cancers by immune response may improve diagnostics and treatments
2.
Study: Discovery of cellular identity may influence cancer treatment
3.
Reversing the toxic relationship with high doses of chemotherapy in oncology.
4.
Coupling dye and fiducial marking can improve precision in pulmonary nodule surgical resection
5.
Timely 'Nudges' Can Help Encourage More End-of-Life Conversations in Cancer
Conferences That Might Interest You
Recommended Articles For You
1.
Uncovering the Mysteries of Breast Cancer: The Journey to a Cure
2.
Critical Care Updates on Critical Illness Management in Patients Receiving Active Cancer Care
3.
Octreotide's Efficacy in Reducing Transfusion Requirements in Angiodysplasia Bleeding
4.
Unveiling the Mystery of Echinocyte: A Closer Look at the Unique Red Blood Cell
5.
The Latest Advances in Glioblastoma Treatment and Prevention
Boost Your Knowledge With These Quizzes
1.
Quiz On Graves Disease Management
2.
Quiz On Amoxicillin Use in Patients
3.
Quiz On Flegel Disease Management
4.
Unraveling the Mysteries of Vitamin B12 and Folate Deficiency: A Quiz for Clinicians
5.
Quiz on The Impact of Genomic Profiling on Lung Cancer Management: How Well Do You Understand Its Role in Personalizing Treatment?
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Welcome to Hidoc Dr.
Join to enhance your clinical skills and gain specialized in-depth medical knowledge